Rapid, point‐of‐care antigen tests for diagnosis of SARS‐CoV‐2 infection

J Dinnes, P Sharma, S Berhane… - Cochrane database …, 2022 - cochranelibrary.com
Background Accurate rapid diagnostic tests for SARS‐CoV‐2 infection would be a useful
tool to help manage the COVID‐19 pandemic. Testing strategies that use rapid antigen tests …

COVID‐19: Virology, biology and novel laboratory diagnosis

M Mohamadian, H Chiti, A Shoghli… - The journal of gene …, 2021 - Wiley Online Library
Background At the end of December 2019, a novel coronavirus tentatively named SARS‐
CoV‐2 in Wuhan, a central city in China, was announced by the World Health Organization …

Diagnostic performance of CT and reverse transcriptase polymerase chain reaction for coronavirus disease 2019: a meta-analysis

H Kim, H Hong, SH Yoon - Radiology, 2020 - pubs.rsna.org
Background Recent studies have suggested that chest CT scans could be used as a primary
screening or diagnostic tool for coronavirus disease 2019 (COVID-19) in epidemic areas …

STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration

JF Cohen, DA Korevaar, DG Altman, DE Bruns… - BMJ open, 2016 - bmjopen.bmj.com
Diagnostic accuracy studies are, like other clinical studies, at risk of bias due to
shortcomings in design and conduct, and the results of a diagnostic accuracy study may not …

[HTML][HTML] Epidemiological and clinical aspects of COVID-19; a narrative review

G Kolifarhood, M Aghaali, HM Saadati… - Archives of academic …, 2020 - ncbi.nlm.nih.gov
There are significant misconceptions and many obstacles in the way of illuminating the
epidemiological and clinical aspects of COVID-19 as a new emerging epidemic. In addition …

Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults

JS Zifodya, I Schiller, N Dendukuri… - Cochrane Database …, 2019 - cochranelibrary.com
Background Xpert MTB/RIF (Xpert MTB/RIF) and Xpert MTB/RIF Ultra (Xpert Ultra), the
newest version, are the only World Health Organization (WHO)‐recommended rapid tests …

[PDF][PDF] COMPAS risk scales: Demonstrating accuracy equity and predictive parity

W Dieterich, C Mendoza, T Brennan - Northpointe Inc, 2016 - go.volarisgroup.com
COMPAS Risk Scales: Demonstrating Accuracy Equity and Predictive Parity Page 1 COMPAS
Risk Scales: Demonstrating Accuracy Equity and Predictive Parity Performance of the …

External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges

RD Riley, J Ensor, KIE Snell, TPA Debray, DG Altman… - bmj, 2016 - bmj.com
Access to big datasets from e-health records and individual participant data (IPD) meta-
analysis is signalling a new advent of external validation studies for clinical prediction …

Prevalence of malnutrition comparing NRS2002, MUST, and PG-SGA with the GLIM criteria in adults with cancer: A multi-center study

Z Zhang, Z Wan, Y Zhu, L Zhang, L Zhang, H Wan - Nutrition, 2021 - Elsevier
Objectives This study aimed to evaluate the diagnostic capacity of the Nutritional Risk
Screening 2002 (NRS2002), Malnutrition Universal Screening Tool (MUST), and Patient …

Xpert® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance

M Kohli, I Schiller, N Dendukuri… - Cochrane Database …, 2018 - cochranelibrary.com
Background Tuberculosis (TB) is the world's leading infectious cause of death.
Extrapulmonary TB accounts for 15% of TB cases, but the proportion is increasing, and over …